Chemours appoints Pamela Fletcher to board; Sandra Phillips Rogers not standing for reelection

Chemours Co

Sandra P. Rogers will not seek reelection at 2024 annual meeting; decision not due to any disagreement with company.
Pamela F. Fletcher appointed as director effective March 1, 2024; board expands from 9 to 10 members.
Fletcher appointed to Compensation and Leadership Development Committee and Nominating and Corporate Governance Committee.
Fletcher previously served as Delta Airlines CSO and GM Vice President; receives standard director compensation ($105k cash, $160k equity).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pamela F. Fletcher

Director

CC · Chemours Co

Effective: 2024-03-01
Filed: February 16, 2024, 6:59 PM ET

On February 13, 2024, the Board appointed Pamela F. Fletcher as a member of the Board, effective March 1, 2024.

Departed

Sandra P. Rogers

Director

CC · Chemours Co

Filed: February 16, 2024, 6:59 PM ET

On February 12, 2024, Sandra P. Rogers notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of her decision not to seek re-election to the Board at the Company’s 2024 Annual Meeting of Stockholders, when her current term expires.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pamela F. Fletcher was appointed as Director at Chemours Co.

Action: appointed
Role: Director

Exact text from the filing

On February 13, 2024, the Board appointed Pamela F. Fletcher as a member of the Board, effective March 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandra P. Rogers departed as Director at Chemours Co.

Action: not seeking re-election
Role: Director

Exact text from the filing

On February 12, 2024, Sandra P. Rogers notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of her decision not to seek re-election to the Board at the Company’s 2024 Annual Meeting of Stockholders, when her current term expires.

View on SEC.gov

Chemours Co filing history →

Source: SEC EDGAR

accession 0000950170-24-016376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.